Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

Cloretazine (VNP40101M) is a newly synthesized alkylating agent belonging to a novel class of alkylating agents called 1,2-bis(sulfonyl)hydrazines. Agents that belong to this class do not produce vinylating and chloroethylating species, and hence this class of alkylating agents is thought to have mi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Badruddoja, Michael A., Penne, Kara, Desjardins, Annick, Reardon, David A., Rich, Jeremy N., Quinn, Jennifer A., Sathornsumetee, Sith, Friedman, Allan H., Bigner, Darell D., Herndon, James E., Cahill, Ann, Friedman, Henry S., Vredenburgh, James J.
Formato: Artigo
Idioma:Inglês
Publicado em: Duke University Press 2007
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1828104/
https://ncbi.nlm.nih.gov/pubmed/17108065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2006-022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados